|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 201 to 300 out of 304 for Pon1

0.041s
Type Details Score
GXD Expression      
Probe: MGI:5310482
Assay Type: RNA in situ
Annotation Date: 2012-06-12
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:3599822
Stage: TS22
Assay Id: MGI:5423805
Age: embryonic day 14.5
Specimen Label: EH955; Specimen C2512
Detected: false
Specimen Num: 1
GXD Expression      
Probe: MGI:5310482
Assay Type: RNA in situ
Annotation Date: 2012-06-12
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:3280922
Stage: TS22
Assay Id: MGI:5423805
Age: embryonic day 14.5
Specimen Label: EH955; Specimen C2512
Detected: false
Specimen Num: 1
GXD Expression      
Probe: MGI:5310482
Assay Type: RNA in situ
Annotation Date: 2012-06-12
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1833322
Stage: TS22
Assay Id: MGI:5423805
Age: embryonic day 14.5
Specimen Label: EH955; Specimen C2512
Detected: false
Specimen Num: 1
GXD Expression      
Probe: MGI:5310482
Assay Type: RNA in situ
Annotation Date: 2012-06-12
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:3287022
Stage: TS22
Assay Id: MGI:5423805
Age: embryonic day 14.5
Specimen Label: EH955; Specimen C2512
Detected: false
Specimen Num: 1
GXD Expression      
Probe: MGI:5310482
Assay Type: RNA in situ
Annotation Date: 2012-06-12
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1752522
Stage: TS22
Assay Id: MGI:5423805
Age: embryonic day 14.5
Specimen Label: EH955; Specimen C2512
Detected: false
Specimen Num: 1
GXD Expression      
Probe: MGI:5310482
Assay Type: RNA in situ
Annotation Date: 2012-06-12
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1821522
Stage: TS22
Assay Id: MGI:5423805
Age: embryonic day 14.5
Specimen Label: EH955; Specimen C2512
Detected: false
Specimen Num: 1
GXD Expression      
Probe: MGI:5310482
Assay Type: RNA in situ
Annotation Date: 2012-06-12
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:3557722
Stage: TS22
Assay Id: MGI:5423805
Age: embryonic day 14.5
Specimen Label: EH955; Specimen C2512
Detected: false
Specimen Num: 1
GXD Expression      
Probe: MGI:5310482
Assay Type: RNA in situ
Annotation Date: 2012-06-12
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1702122
Stage: TS22
Assay Id: MGI:5423805
Age: embryonic day 14.5
Specimen Label: EH955; Specimen C2512
Detected: false
Specimen Num: 1
GXD Expression      
Probe: MGI:5310482
Assay Type: RNA in situ
Annotation Date: 2012-06-12
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1756322
Stage: TS22
Assay Id: MGI:5423805
Age: embryonic day 14.5
Specimen Label: EH955; Specimen C2512
Detected: false
Specimen Num: 1
GXD Expression      
Probe: MGI:5310482
Assay Type: RNA in situ
Annotation Date: 2012-06-12
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1668822
Stage: TS22
Assay Id: MGI:5423805
Age: embryonic day 14.5
Specimen Label: EH955; Specimen C2512
Detected: false
Specimen Num: 1
GXD Expression      
Probe: MGI:5310482
Assay Type: RNA in situ
Annotation Date: 2012-06-12
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1757722
Stage: TS22
Assay Id: MGI:5423805
Age: embryonic day 14.5
Specimen Label: EH955; Specimen C2512
Detected: false
Specimen Num: 1
GXD Expression      
Probe: MGI:5310482
Assay Type: RNA in situ
Annotation Date: 2012-06-12
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1757522
Stage: TS22
Assay Id: MGI:5423805
Age: embryonic day 14.5
Specimen Label: EH955; Specimen C2512
Detected: false
Specimen Num: 1
GXD Expression      
Probe: MGI:5310482
Assay Type: RNA in situ
Annotation Date: 2012-06-12
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1738322
Stage: TS22
Assay Id: MGI:5423805
Age: embryonic day 14.5
Specimen Label: EH955; Specimen C2512
Detected: false
Specimen Num: 1
GXD Expression      
Probe: MGI:5310482
Assay Type: RNA in situ
Annotation Date: 2012-06-12
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1802422
Stage: TS22
Assay Id: MGI:5423805
Age: embryonic day 14.5
Specimen Label: EH955; Specimen C2512
Detected: false
Specimen Num: 1
GXD Expression    
Probe: MGI:5310482
Assay Type: RNA in situ
Annotation Date: 2012-06-12
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1768022
Stage: TS22
Assay Id: MGI:5423805
Age: embryonic day 14.5
Note: Expression was not detected in the skull (base and vault).
Specimen Label: EH955; Specimen C2512
Detected: false
Specimen Num: 1
GXD Expression    
Probe: MGI:5310482
Assay Type: RNA in situ
Annotation Date: 2012-06-12
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:2672022
Stage: TS22
Assay Id: MGI:5423805
Age: embryonic day 14.5
Note: Expression was not detected in whisker follicle.
Specimen Label: EH955; Specimen C2512
Detected: false
Specimen Num: 1
Publication
First Author: Yamashita J
Year: 2013
Journal: J Immunol
Title: Paraoxonase-1 suppresses experimental colitis via the inhibition of IFN-γ production from CD4 T cells.
Volume: 191
Issue: 2
Pages: 949-60
Publication
First Author: Tong L
Year: 1996
Journal: J Neurosci Res
Title: Effect of nerve growth factor on AP-1, NF-kappa B, and Oct DNA binding activity in apoptotic PC12 cells: extrinsic and intrinsic elements.
Volume: 45
Issue: 1
Pages: 1-12
Publication
First Author: Kalyuzhny AE
Year: 1997
Journal: Anat Embryol (Berl)
Title: Immunocytochemical localization of mu-opioid receptors in follicular cells and preimplantation mouse embryos.
Volume: 195
Issue: 5
Pages: 451-5
Publication
First Author: Forte TM
Year: 1999
Journal: J Lipid Res
Title: Targeted disruption of the murine lecithin:cholesterol acyltransferase gene is associated with reductions in plasma paraoxonase and platelet-activating factor acetylhydrolase activities but not in apolipoprotein J concentration.
Volume: 40
Issue: 7
Pages: 1276-83
Publication
First Author: Forte TM
Year: 2002
Journal: J Lipid Res
Title: Altered activities of anti-atherogenic enzymes LCAT, paraoxonase, and platelet-activating factor acetylhydrolase in atherosclerosis-susceptible mice.
Volume: 43
Issue: 3
Pages: 477-85
Publication
First Author: Luciano-Mateo F
Year: 2019
Journal: Biochim Biophys Acta Mol Basis Dis
Title: Chemokine (C-C motif) ligand 2 gene ablation protects low-density lipoprotein and paraoxonase-1 double deficient mice from liver injury, oxidative stress and inflammation.
Volume: 1865
Issue: 6
Pages: 1555-1566
Publication
First Author: McNally EM
Year: 1998
Journal: FEBS Lett
Title: Human epsilon-sarcoglycan is highly related to alpha-sarcoglycan (adhalin), the limb girdle muscular dystrophy 2D gene.
Volume: 422
Issue: 1
Pages: 27-32
Publication
First Author: Ono R
Year: 2003
Journal: Genome Res
Title: Identification of a large novel imprinted gene cluster on mouse proximal chromosome 6.
Volume: 13
Issue: 7
Pages: 1696-705
Publication
First Author: Reynolds SD
Year: 2008
Journal: Stem Cells
Title: Conditional stabilization of beta-catenin expands the pool of lung stem cells.
Volume: 26
Issue: 5
Pages: 1337-46
Publication
First Author: Zemke AC
Year: 2009
Journal: Am J Respir Cell Mol Biol
Title: Molecular staging of epithelial maturation using secretory cell-specific genes as markers.
Volume: 40
Issue: 3
Pages: 340-8
Publication
First Author: Sayin VI
Year: 2013
Journal: PLoS One
Title: Zfp148 deficiency causes lung maturation defects and lethality in newborn mice that are rescued by deletion of p53 or antioxidant treatment.
Volume: 8
Issue: 2
Pages: e55720
Publication
First Author: Briquet-Laugier V
Year: 1998
Journal: Mamm Genome
Title: Mapping of three members of the mouse protein disulfide isomerase family.
Volume: 9
Issue: 2
Pages: 176-7
Publication
First Author: Ono R
Year: 2006
Journal: Nat Genet
Title: Deletion of Peg10, an imprinted gene acquired from a retrotransposon, causes early embryonic lethality.
Volume: 38
Issue: 1
Pages: 101-6
Publication
First Author: Xu Y
Year: 2012
Journal: PLoS One
Title: Transcriptional programs controlling perinatal lung maturation.
Volume: 7
Issue: 8
Pages: e37046
Publication
First Author: Moon S
Year: 2018
Journal: Cell Death Dis
Title: Asxl1 exerts an antiproliferative effect on mouse lung maturation via epigenetic repression of the E2f1-Nmyc axis.
Volume: 9
Issue: 11
Pages: 1118
Publication
First Author: Besnard V
Year: 2011
Journal: PLoS One
Title: Maternal synchronization of gestational length and lung maturation.
Volume: 6
Issue: 11
Pages: e26682
Publication
First Author: Chung C
Year: 2013
Journal: Proc Natl Acad Sci U S A
Title: Hippo-Foxa2 signaling pathway plays a role in peripheral lung maturation and surfactant homeostasis.
Volume: 110
Issue: 19
Pages: 7732-7
Publication
First Author: Pei L
Year: 2011
Journal: Nat Med
Title: Thyroid hormone receptor repression is linked to type I pneumocyte-associated respiratory distress syndrome.
Volume: 17
Issue: 11
Pages: 1466-72
Publication
First Author: Welch CL
Year: 1996
Journal: J Lipid Res
Title: Genetic regulation of cholesterol homeostasis: chromosomal organization of candidate genes.
Volume: 37
Issue: 7
Pages: 1406-21
Publication      
First Author: Freeman TC
Year: 1998
Journal: MGI Direct Data Submission
Title: Expression Mapping of Mouse Genes
Publication        
First Author: GO Central curators, GOA curators, Rhea curators
Year: 2020
Title: Automatic Gene Ontology annotation based on Rhea mapping
Publication        
First Author: GOA curators, MGI curators
Year: 2001
Title: Gene Ontology annotation based on Enzyme Commission mapping
Publication
First Author: Visel A
Year: 2004
Journal: Nucleic Acids Res
Title: GenePaint.org: an atlas of gene expression patterns in the mouse embryo.
Volume: 32
Issue: Database issue
Pages: D552-6
Publication      
First Author: Velocigene
Year: 2008
Journal: MGI Direct Data Submission
Title: Alleles produced for the KOMP project by Velocigene (Regeneron Pharmaceuticals)
Publication      
First Author: Wellcome Trust Sanger Institute
Year: 2009
Journal: MGI Direct Data Submission
Title: Alleles produced for the KOMP project by the Wellcome Trust Sanger Institute
Publication        
First Author: The Gene Ontology Consortium
Year: 2014
Title: Automated transfer of experimentally-verified manual GO annotation data to mouse-rat orthologs
Publication
First Author: Magdaleno S
Year: 2006
Journal: PLoS Biol
Title: BGEM: an in situ hybridization database of gene expression in the embryonic and adult mouse nervous system.
Volume: 4
Issue: 4
Pages: e86
Publication        
First Author: MGD Nomenclature Committee
Year: 1995
Title: Nomenclature Committee Use
Publication        
First Author: GemPharmatech
Year: 2020
Title: GemPharmatech Website.
Publication
First Author: Skarnes WC
Year: 2011
Journal: Nature
Title: A conditional knockout resource for the genome-wide study of mouse gene function.
Volume: 474
Issue: 7351
Pages: 337-42
Publication        
First Author: Cyagen Biosciences Inc.
Year: 2022
Title: Cyagen Biosciences Website.
Publication        
First Author: AgBase, BHF-UCL, Parkinson's UK-UCL, dictyBase, HGNC, Roslin Institute, FlyBase and UniProtKB curators
Year: 2011
Title: Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity
Publication        
First Author: GOA curators
Year: 2016
Title: Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara
Publication
First Author: Okazaki Y
Year: 2002
Journal: Nature
Title: Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs.
Volume: 420
Issue: 6915
Pages: 563-73
Publication        
First Author: The Gene Ontology Consortium
Year: 2010
Title: Automated transfer of experimentally-verified manual GO annotation data to mouse-human orthologs
Publication
First Author: Diez-Roux G
Year: 2011
Journal: PLoS Biol
Title: A high-resolution anatomical atlas of the transcriptome in the mouse embryo.
Volume: 9
Issue: 1
Pages: e1000582
Publication      
First Author: Mouse Genome Informatics Scientific Curators
Year: 2010
Journal: Database Download
Title: Mouse Microarray Data Integration in Mouse Genome Informatics, the Affymetrix GeneChip Mouse Genome U74 Array Platform (A, B, C v2).
Publication      
First Author: MGI Genome Annotation Group and UniGene Staff
Year: 2015
Journal: Database Download
Title: MGI-UniGene Interconnection Effort
Publication        
First Author: Marc Feuermann, Huaiyu Mi, Pascale Gaudet, Dustin Ebert, Anushya Muruganujan, Paul Thomas
Year: 2010
Title: Annotation inferences using phylogenetic trees
Publication      
First Author: Mouse Genome Database and National Center for Biotechnology Information
Year: 2000
Journal: Database Release
Title: Entrez Gene Load
Publication      
First Author: Allen Institute for Brain Science
Year: 2004
Journal: Allen Institute
Title: Allen Brain Atlas: mouse riboprobes
Publication      
First Author: Mouse Genome Informatics Scientific Curators
Year: 2009
Journal: Database Download
Title: Mouse Microarray Data Integration in Mouse Genome Informatics, the Affymetrix GeneChip Mouse Gene 1.0 ST Array Platform
Publication      
First Author: Mouse Genome Informatics (MGI) and The National Center for Biotechnology Information (NCBI)
Year: 2010
Journal: Database Download
Title: Consensus CDS project
Publication      
First Author: Mouse Genome Informatics Group
Year: 2003
Journal: Database Procedure
Title: Automatic Encodes (AutoE) Reference
Publication      
First Author: Bairoch A
Year: 1999
Journal: Database Release
Title: SWISS-PROT Annotated protein sequence database
Publication        
First Author: Mouse Genome Informatics Scientific Curators
Year: 2005
Title: Obtaining and Loading Genome Assembly Coordinates from Ensembl Annotations
Publication      
First Author: Mouse Genome Informatics
Year: 2010
Journal: Database Release
Title: Protein Ontology Association Load.
Publication        
First Author: Mouse Genome Informatics Scientific Curators
Year: 2005
Title: Obtaining and loading genome assembly coordinates from NCBI annotations
Publication      
First Author: Mouse Genome Informatics Scientific Curators
Year: 2009
Journal: Database Download
Title: Mouse Microarray Data Integration in Mouse Genome Informatics, the Affymetrix GeneChip Mouse Genome 430 2.0 Array Platform
Publication
First Author: Aharoni A
Year: 2004
Journal: Proc Natl Acad Sci U S A
Title: Directed evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specialization.
Volume: 101
Issue: 2
Pages: 482-7
Transgene
Type: transgene
Organism: mouse, laboratory
Publication
First Author: Ikhlef S
Year: 2017
Journal: PLoS One
Title: Human paraoxonase 1 overexpression in mice stimulates HDL cholesterol efflux and reverse cholesterol transport.
Volume: 12
Issue: 3
Pages: e0173385
Publication
First Author: Lu J
Year: 2013
Journal: Biochem Biophys Res Commun
Title: Role of paraoxonase-1 in bone anabolic effects of parathyroid hormone in hyperlipidemic mice.
Volume: 431
Issue: 1
Pages: 19-24
Publication
First Author: Bradshaw G
Year: 2005
Journal: Proc Natl Acad Sci U S A
Title: Facilitated replacement of Kupffer cells expressing a paraoxonase-1 transgene is essential for ameliorating atherosclerosis in mice.
Volume: 102
Issue: 31
Pages: 11029-34
Publication
First Author: Charles-Schoeman C
Year: 2020
Journal: Sci Rep
Title: Suppression of inflammatory arthritis in human serum paraoxonase 1 transgenic mice.
Volume: 10
Issue: 1
Pages: 16848
Allele
Name: transgene insertion 1, Roger A Davis
Allele Type: Transgenic
Attribute String: Inserted expressed sequence
Strain
Attribute String: coisogenic, mutant strain, transgenic
Publication
First Author: Hegele RA
Year: 1995
Journal: Arterioscler Thromb Vasc Biol
Title: A polymorphism of the paraoxonase gene associated with variation in plasma lipoproteins in a genetic isolate.
Volume: 15
Issue: 1
Pages: 89-95
Protein Domain
Type: Family
Description: The serum paraoxonases/arylesterases are enzymes that catalyse the hydrolysisof the toxic metabolites of a variety of organophosphorus insecticides. Theenzymes hydrolyse a broad spectrum of organophosphate substrates, including paraoxon and a number of aromatic carboxylic acid esters (e.g., phenylacetate), and hence confer resistance to organophosphate toxicity []. Mammals have 3 distinct paraoxonase types, termed PON1-3 [, ]. In mice andhumans, the PON genes are found on the same chromosome in close proximity. PON activity has been found in variety of tissues, with highest levels in liver and serum - the source of serum PON is thought to be the liver. Unlike mammals, fish and avian species lack paraoxonase activity. Human and rabbit PONs appear to have two distinct Ca2+ binding sites, onerequired for stability and one required for catalytic activity. The Ca2+dependency of PONs suggests a mechanism of hydrolysis where Ca2+ acts as theelectrophillic catalyst, like that proposed for phospholipase A2. Theparaoxonase enzymes, PON1 and PON3, are high density lipoprotein (HDL)-associated proteins capable of preventing oxidative modification of lowdensity lipoproteins (LPL) []. Although PON2 has oxidative properties, theenzyme does not associate with HDL.Within a given species, PON1, PON2 and PON3 share ~60% amino acid sequence identity, whereas between mammalian species particular PONs (1,2 or 3) share79-90% identity at the amino acid level. Human PON1 and PON3 share numerous conserved phosphorylation and N-glycosylation sites; however, it is not known whether the PON proteins are modified at these sites, or whether modification at these sites is required for activity in vivo []. Rabbit and human serum PON1 also hydrolyse a variety oflactones and cycliccarbonate esters, including naturally occurring lactones and pharmacologicalagents []. Humans have 2 common PON1 allozymes, determined by the presenceof either arginine or glutamine at position 191. The A-type allozyme (glutamine at position 191) causes low paraoxonase activity []; thispolymorphism is associated with variations in cholesterol and lipoproteinlevels.
Protein Domain
Type: Domain
Description: This family describes a region that is found in proteins expressed by a variety of eukaryotic and prokaryotic species. These proteins include various enzymes, such as senescence marker protein 30 (SMP-30, ), gluconolactonase () and luciferin-regenerating enzyme (LRE, ). SMP-30 is known to hydrolyse diisopropyl phosphorofluoridate in the liver, and has been noted as having sequence similarity, in the region described in this family, with PON1 () and LRE.
Publication
First Author: Billecke S
Year: 2000
Journal: Drug Metab Dispos
Title: Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters.
Volume: 28
Issue: 11
Pages: 1335-42
Protein Domain
Type: Family
Description: The serum paraoxonases/arylesterases are enzymes that catalyse the hydrolysisof the toxic metabolites of a variety of organophosphorus insecticides. Theenzymes hydrolyse a broad spectrum of organophosphate substrates, including paraoxon and a number of aromatic carboxylic acid esters (e.g., phenylacetate), and hence confer resistance to organophosphate toxicity []. Mammals have 3 distinct paraoxonase types, termed PON1-3 [, ]. In mice andhumans, the PON genes are found on the same chromosome in close proximity. PON activity has been found in variety of tissues, with highest levels in liver and serum - the source of serum PON is thought to be the liver. Unlike mammals, fish and avian species lack paraoxonase activity. Human and rabbit PONs appear to have two distinct Ca2+ binding sites, onerequired for stability and one required for catalytic activity. The Ca2+dependency of PONs suggests a mechanism of hydrolysis where Ca2+ acts as theelectrophillic catalyst, like that proposed for phospholipase A2. Theparaoxonase enzymes, PON1 and PON3, are high density lipoprotein (HDL)-associated proteins capable of preventing oxidative modification of lowdensity lipoproteins (LPL) []. Although PON2 has oxidative properties, theenzyme does not associate with HDL.Within a given species, PON1, PON2 and PON3 share ~60% amino acid sequence identity, whereas between mammalian species particular PONs (1,2 or 3) share79-90% identity at the amino acid level. Human PON1 and PON3 share numerous conserved phosphorylation and N-glycosylation sites; however, it is not known whether the PON proteins are modified at these sites, or whether modification at these sites is required for activity in vivo [].
Publication
First Author: Ikhlef S
Year: 2016
Journal: FEBS Lett
Title: Paraoxonase 1-treated oxLDL promotes cholesterol efflux from macrophages by stimulating the PPARγ-LXRα-ABCA1 pathway.
Volume: 590
Issue: 11
Pages: 1614-29
Publication  
First Author: Rodrigo L
Year: 1997
Journal: Biochem J
Title: Purification and characterization of paraoxon hydrolase from rat liver.
Volume: 321 ( Pt 3)
Pages: 595-601
Protein Domain
Type: Family
Description: The serum paraoxonases/arylesterases are enzymes that catalyse the hydrolysisof the toxic metabolites of a variety of organophosphorus insecticides. Theenzymes hydrolyse a broad spectrum of organophosphate substrates, including paraoxon and a number of aromatic carboxylic acid esters (e.g., phenylacetate), and hence confer resistance to organophosphate toxicity []. Mammals have 3 distinct paraoxonase types, termed PON1-3 [, ]. In mice andhumans, the PON genes are found on the same chromosome in close proximity. PON activity has been found in variety of tissues, with highest levels in liver and serum - the source of serum PON is thought to be the liver. Unlike mammals, fish and avian species lack paraoxonase activity. Human and rabbit PONs appear to have two distinct Ca2+ binding sites, onerequired for stability and one required for catalytic activity. The Ca2+dependency of PONs suggests a mechanism of hydrolysis where Ca2+ acts as theelectrophillic catalyst, like that proposed for phospholipase A2. Theparaoxonase enzymes, PON1 and PON3, are high density lipoprotein (HDL)-associated proteins capable of preventing oxidative modification of lowdensity lipoproteins (LPL) []. Although PON2 has oxidative properties, theenzyme does not associate with HDL.Within a given species, PON1, PON2 and PON3 share ~60% amino acid sequence identity, whereas between mammalian species particular PONs (1,2 or 3) share79-90% identity at the amino acid level. Human PON1 and PON3 share numerous conserved phosphorylation and N-glycosylation sites; however, it is not known whether the PON proteins are modified at these sites, or whether modification at these sites is required for activity in vivo []. This family consists of arylesterases (Also known as serum paraoxonase) . These enzymes hydrolyse organophosphorus esters such as paraoxon and are found in the liver and blood. They confer resistance to organophosphate toxicity []. Human arylesterase (PON1) is associated with HDL and may protect against LDL oxidation [].
Protein
Organism: Mus musculus/domesticus
Length: 355  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 181  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 256  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 200  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 108  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 135  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 354  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 354  
Fragment?: false
Publication
First Author: Wang W
Year: 2010
Journal: J Lipid Res
Title: Genetic deletion of apolipoprotein A-I increases airway hyperresponsiveness, inflammation, and collagen deposition in the lung.
Volume: 51
Issue: 9
Pages: 2560-70
Publication
First Author: Zamanian-Daryoush M
Year: 2020
Journal: J Biol Chem
Title: Site-specific 5-hydroxytryptophan incorporation into apolipoprotein A-I impairs cholesterol efflux activity and high-density lipoprotein biogenesis.
Volume: 295
Issue: 15
Pages: 4836-4848
Publication
First Author: Robert K
Year: 2003
Journal: J Biol Chem
Title: Altered gene expression in liver from a murine model of hyperhomocysteinemia.
Volume: 278
Issue: 34
Pages: 31504-11
Publication
First Author: Shih DM
Year: 2006
Journal: J Lipid Res
Title: A role for FXR and human FGF-19 in the repression of paraoxonase-1 gene expression by bile acids.
Volume: 47
Issue: 2
Pages: 384-92
Publication
First Author: She ZG
Year: 2009
Journal: Circ Res
Title: Human paraoxonase gene cluster transgenic overexpression represses atherogenesis and promotes atherosclerotic plaque stability in ApoE-null mice.
Volume: 104
Issue: 10
Pages: 1160-8
Publication
First Author: Giordano G
Year: 2011
Journal: Toxicol Appl Pharmacol
Title: Paraoxonase 2 (PON2) in the mouse central nervous system: a neuroprotective role?
Volume: 256
Issue: 3
Pages: 369-78
Publication
First Author: Ng CJ
Year: 2006
Journal: J Biol Chem
Title: Paraoxonase-2 deficiency aggravates atherosclerosis in mice despite lower apolipoprotein-B-containing lipoproteins: anti-atherogenic role for paraoxonase-2.
Volume: 281
Issue: 40
Pages: 29491-500
Publication
First Author: Teiber JF
Year: 2018
Journal: Biochem Biophys Res Commun
Title: Identification of biologically active δ-lactone eicosanoids as paraoxonase substrates.
Volume: 505
Issue: 1
Pages: 87-92
Publication
First Author: Belinskaya T
Year: 2012
Journal: Biochim Biophys Acta
Title: Differences in amino acid residues in the binding pockets dictate substrate specificities of mouse senescence marker protein-30, human paraoxonase1, and squid diisopropylfluorophosphatase.
Volume: 1824
Issue: 5
Pages: 701-10
Publication
First Author: Khateeb J
Year: 2012
Journal: Arterioscler Thromb Vasc Biol
Title: Urokinase-type plasminogen activator downregulates paraoxonase 1 expression in hepatocytes by stimulating peroxisome proliferator-activated receptor-γ nuclear export.
Volume: 32
Issue: 2
Pages: 449-58
Publication  
First Author: DeGroot DE
Year: 2014
Journal: Arch Biochem Biophys
Title: Lack of ligand-selective binding of the aryl hydrocarbon receptor to putative DNA binding sites regulating expression of Bax and paraoxonase 1 genes.
Volume: 541
Pages: 13-20